MedPath

BELBUCA

These highlights do not include all the information needed to use BELBUCA safely and effectively. See full prescribing information for BELBUCA. BELBUCA (buprenorphine buccal film), CIII Initial U.S. Approval: 1981

Approved
Approval ID

bc2b7a3d-72cf-497c-95b0-ba2b71f63c64

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2023

Manufacturers
FDA

BioDelivery Sciences International Inc

DUNS: 016058955

Products 7

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-022
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

buprenorphine hydrochlorideActive
Quantity: 150 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-023
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
buprenorphine hydrochlorideActive
Quantity: 300 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-021
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

buprenorphine hydrochlorideActive
Quantity: 75 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-027
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
buprenorphine hydrochlorideActive
Quantity: 900 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-025
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
buprenorphine hydrochlorideActive
Quantity: 600 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-024
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

buprenorphine hydrochlorideActive
Quantity: 450 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

buprenorphine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59385-026
Application NumberNDA207932
Product Classification
M
Marketing Category
C73594
G
Generic Name
buprenorphine hydrochloride
Product Specifications
Route of AdministrationBUCCAL
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (17)

buprenorphine hydrochlorideActive
Quantity: 750 ug in 1 1
Code: 56W8MW3EN1
Classification: ACTIM
HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%)Inactive
Code: B24JYI97VR
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Sodium BenzoateInactive
Code: OJ245FE5EU
Classification: IACT
MethylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
PropylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRT
Classification: IACT
Peppermint OilInactive
Code: AV092KU4JH
Classification: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
HYDROXYPROPYL CELLULOSE (90000 WAMW)Inactive
Code: UKE75GEA7F
Classification: IACT
PolycarbophilInactive
Code: W25LM17A4W
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%)Inactive
Code: YGX74DKE74
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.